New research reveals promising drug targets to block coronaviruses at multiple stages of infection—even across different ...

From L-R, Garcia, Wahl and Battaglia Approximately 15 million to 20 million Americans who have acquired COVID-19 experience ...

Despite vaccines and treatments, SARS-CoV-2-the virus that causes COVID-19-continues to pose a global health threat, driven ...

The COVID-19 virus hijacks the machinery of testicular cells that produce the hormone testosterone in order to replicate. It also appropriates the metabolic pathways of these cells and cholesterol, a ...

SARS-CoV-2 infection is linked with early vascular aging in the long term, especially in women, according to a recent study in the European Heart Journal. In the multicenter CARTESIAN study, ...

Gilead Sciences Inc. has identified 3C-like proteinase (3CLpro; Mpro; nsp5) (SARS-CoV-2; COVID-19 virus) inhibitors reported to be useful for the treatment of SARS-CoV-2 infection (COVID-19).

W ith artificial intelligence beginning to eat away at many white-collar entry-level jobs, and the unemployment rate for recent college graduates currently higher than the overall rate, it’s easy to ...